Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve (LFCN) Block or Wound Infiltration for Postoperative Analgesia in Anterior Approach Total Hip Arthroplasty: A Randomized Controlled Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOspedale Edoardo Bassini

About this trial

This prospective, randomized controlled trial aims to compare two multimodal regional anesthesia strategies for postoperative analgesia in elective total hip arthroplasty (THA) performed via anterior approach. Patients will be randomized to receive either a Pericapsular Nerve Group (PENG) block combined with a Lateral Femoral Cutaneous Nerve (LFCN) block, or a PENG block combined with wound infiltration (WI).

The primary outcome is postoperative pain intensity at rest, measured by Numerical Rating Scale (NRS) at 6 hours after surgery. Secondary outcomes include dynamic pain scores at 6, 24, and 48 hours, total opioid consumption, time to first rescue analgesia, quadriceps strength, hip flexion angle, length of stay, and adverse events.

All procedures are routinely used in clinical practice and carry minimal additional risk. Safety will be continuously monitored by the Principal Investigator and the study team according to an internal Safety Monitoring Plan.

Eligibility criteria

Qualifiers

Age > 18 years

Elective total hip arthroplasty

Spinal (subarachnoid) anesthesia

Written informed consent provided by the patient or by the legal guardian, if appointed

Disqualifiers

INR > 1.5

aPTT > 1.5

Platelet count < 75,000/mm³

Signs suggestive of infection at the puncture site

Trial design

Treatments tested in this trial

  • PENG plus LFCN block
  • PENG plus WI

Treatment groups

102 Participants
are divided into 2 treatment groups

Sponsors and collaborators